CSIMarket Company Name, Ticker, Competitors, else..
 
Hcw Biologics Inc   (NASDAQ: HCWB)
Other Ticker:  
 
 
Price: $0.3700 $0.01 3.237%
Day's High: $0.38 Week Perf: 1.65 %
Day's Low: $ 0.33 30 Day Perf: 3.96 %
Volume (M): 98 52 Wk High: $ 2.52
Volume (M$): $ 36 52 Wk Avg: $0.86
Open: $0.35 52 Wk Low: $0.28



 Market Capitalization (Millions $) 14
 Shares Outstanding (Millions) 38
 Employees -
 Revenues (TTM) (Millions $) 3
 Net Income (TTM) (Millions $) -37
 Cash Flow (TTM) (Millions $) -10
 Capital Exp. (TTM) (Millions $) 4

Hcw Biologics Inc
HCW Biologics Inc. is a biopharmaceutical company that specializes in the research, development, and manufacturing of biotherapeutics and vaccines. The company focuses on utilizing innovative technologies and scientific processes to develop advanced treatments for various medical conditions. They aim to advance the field of biomedicine by creating safe and effective products that improve patient outcomes.


   Company Address: 2929 N Miramar 33025 FL
   Company Phone Number: 842?2024   Stock Exchange / Ticker: NASDAQ HCWB


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABBV   -2.93%    
BMY        1.68% 
JNJ        1.77% 
LLY   -9%    
MRK   -3.03%    
PFE   -1.87%    
• View Complete Report
   



Hcw Biologics Inc

HCWB: Navigating Stormy Waters, Poised for a Resurgence



In the ever-changing world of the stock market, companies often face financial ups and downs. HCWB, despite its recent challenges in the third quarter of 2023, is poised to bounce back and continue its growth trajectory. Although the financial report may seem bleak at first glance, there are several positive indicators that suggest a brighter future lies ahead for HCWB.
Revenue Decline but Positive Comparative Growth:
The recently released financial report shows a significant decline in revenue, dropping by -52.842% to $0.85 million compared to the same quarter from the previous year. However, when compared to the preceding quarter, revenue has surged by an impressive 36.977% from $0.62 million. This positive comparative growth indicates the potential for HCWB to recover and regain its financial stability.
Hcw Biologics Inc

Hcw Biologics Inc Defies Industry Trends with Impressive Revenue Surge of 37.182% in Q2 2023 amid Diminishing Returns



In the volatile realm of the stock market, investors are always on the lookout for companies that display promising growth potential. One such intriguing case is HCW Biologics Inc, a major player in the pharmaceutical preparations industry. In the most recent financial period ending June 30, 2023, HCWBs has defied industry trends by reporting an impressive surge in revenue, despite witnessing diminishing returns on a per-share basis. Let's delve deeper into the financials and uncover some interesting facts about this company.
Revenue Surge Amid Diminishing Returns:
Despite experiencing diminishing returns, HCW Biologics Inc managed to seize a revenue surge of 37.182% in the financial period ending June 30, 2023. Comparing this revenue growth to the corresponding period a year before, when revenue stood at $0.04 million, HCWBs's current revenue of $0.62 million highlights a remarkable shift in its financial performance. This surge stands in contrast to most of its peers in the Major Pharmaceutical Preparations sector, who are witnessing declining top lines during the same period.
Hcw Biologics Inc

HCW Biologics Inc. Faces Deficit Crisis, but Savvy Investors Can Still Profit

Welcome to the exciting world of the stock market! While some may see recent financial news from HCW Biologics Inc as a setback, savvy investors know that there is always potential to profit from market fluctuations.
The company recently declared a disappointing fiscal period, with a significant drop in revenue and an expanded net deficit per share. However, this news only serves to make the company a potentially lucrative target for investors who are able to analyze market trends and make informed decisions.






Hcw Biologics Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com